2016 updated EULAR evidence-based recommendations for the management of gout

P Richette, M Doherty, E Pascual, V Barskova… - Annals of the …, 2017 - ard.bmj.com
Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …

[HTML][HTML] Gout: An old disease in new perspective–A review

G Ragab, M Elshahaly, T Bardin - Journal of advanced research, 2017 - Elsevier
Gout is a picturesque presentation of uric acid disturbance. It is the most well understood
and described type of arthritis. Its epidemiology is studied. New insights into the …

[PDF][PDF] Drug allergy: a 2022 practice parameter update

DA Khan, A Banerji, KG Blumenthal, EJ Phillips… - Journal of Allergy and …, 2022 - Elsevier
Resolving conflict of interest The Joint Task Force on Practice Parameters (JTFPP) is
committed to ensuring that all guidelines are based on the best scientific evidence at the …

Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options

T Bardin, P Richette - BMC medicine, 2017 - Springer
Gout, the most prevalent inflammatory arthritis worldwide, is associated with cardiovascular
and renal diseases, and is an independent predictor of premature death. The frequencies of …

Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the …

A Qaseem, TJ Wilt, R Rich, LL Humphrey… - Annals of internal …, 2017 - acpjournals.org
This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Description: The American College of Physicians (ACP) and the American …

Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians

A Qaseem, RP Harris, MA Forciea… - Annals of internal …, 2017 - acpjournals.org
Description: The American College of Physicians (ACP) developed this guideline to present
the evidence and provide clinical recommendations on the management of gout. Methods …

[HTML][HTML] Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults

DY Hsu, J Brieva, NB Silverberg… - Journal of Investigative …, 2016 - Elsevier
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening
disorders. Our study objective was to describe the incidence, costs of care, length of stay …

Gout: state of the art after a decade of developments

T Pascart, F Lioté - Rheumatology, 2019 - academic.oup.com
This review article summarizes the relevant English literature on gout from 2010 through
April 2017. It emphasizes that the current epidemiology of gout indicates a rising prevalence …

Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response

KD White, WH Chung, SI Hung, S Mallal… - Journal of Allergy and …, 2015 - Elsevier
Immune-mediated (IM) adverse drug reactions (ADRs) are an underrecognized source of
preventable morbidity, mortality, and cost. Increasingly, genetic variation in the HLA loci is …

Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system

YT Cho, CW Yang, CY Chu - International Journal of Molecular Sciences, 2017 - mdpi.com
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe
multiorgan hypersensitivity reaction mostly caused by a limited number of eliciting drugs in …